Participated · Series A · Feb 2025

Superlogic runs a blockchain-enabled loyalty management platform for enterprises. The system converts conventional reward points into on-chain tokens and transforms redeemable products or service experiences into tradable “digital badges.” This structure is designed to give brands tighter control and broader flexibility when running loyalty programs. Its customer roster already includes major payments player American Express, underscoring early commercial validation. By leveraging blockchain, Superlogic aims to increase transparency, interoperability, and user engagement within loyalty ecosystems. Financial metrics such as revenue or user numbers were not disclosed in the article. The company has just secured additional capital to advance its platform and deepen customer relationships.

Participated · Series C · Nov 2023

Urbanic is a fashion brand led by James Wellwood that combines creativity and technology to deliver fashion products. It leverages an AI and machine learning-based model engine and a proprietary Large Language Model trained on a variety of code bases. The company's LLM and AIGC capabilities systematically generate fashion, creativity, and content and are used to improve overall supply-chain efficiency. Urbanic focuses on technology-driven and socially responsible fashion designs. The company plans to use recent funding to accelerate growth and expand these offerings to more global consumers. The article notes a $150M Series C raise to support these initiatives.

Participated · Equity · Aug 2023

Dice operates an event discovery and ticketing platform that focuses on live, in-person events (primarily music) and charges fees to event organizers. The company reports serving “millions” of fans, 55,000 artists and more than 10,000 venues, festivals and promoters across roughly 30 cities. Dice emphasizes first-party discovery data (with limited use of Spotify/Apple scanning) to power personalized recommendations, which account for almost half of ticket sales. It acquired Boiler Room, which the CEO says has been a success as both a broadcaster and IRL event producer. The company is building forecasting and data tools for artists, venues and promoters, with plans to roll more business tools out next year. Dice has largely wound down pandemic-era live streaming activity to refocus on live events. Dice is a mobile-first event discovery and ticketing platform that focuses primarily on live music and curated cultural events, offering discovery, secure digital ticketing and community features. The company built its own dataset and recommendation algorithms to drive discovery, which accounts for more than 40% of tickets sold on the platform. Dice also provides analytics to venues, artists and promoters and uses mobile-based ticketing to limit reselling and counterfeiting while enabling venue-approved resale. During the pandemic Dice pivoted to livestreaming and has run some 6,400 livestreamed events alongside thousands of in-person events; it works with over 3,600 venues. The company reports high localized attendance for in-person shows (about 80–85% of tickets sold to people in major cities) and broader reach for livestreams (only 39% from major cities). Dice plans to expand its geographic footprint with a special focus on the U.S. and to continue innovating on livestreaming and hybrid broadcasting. Dice is a mobile ticketing platform that curates gigs and sells mobile-tied tickets without booking fees, with a focus on helping millennials discover live music. Its app combines human curation and machine-learning recommendations to surface suitable events and a shortlist of suggested gigs. The product includes a waitlist and anti-tout technology and is used by over 700 artists with around 1,400 UK gigs listed; Dice says its app is on roughly 40% of millennials' phones in London. The company employs about 42 people and reports "eight figures" in ticket sale transactions to date, while not yet actively monetizing beyond some sponsored gigs. Planned product work includes a fuller discovery feature and a ticket-transfer function; the team is also preparing international expansion (Dublin next, with a U.S. launch planned) and eyeing other verticals such as theatre and sports. Dice is a mobile-only ticketing app that sells gig tickets at face value with no booking or card transaction fees, tying tickets to buyers' devices to deter touts. The company was founded last December by two co-founders of ustwo alongside music executive Phil Hutcheon and is incubated at ustwo while remaining a separate company. Dice emphasizes curated, editorially selected gigs rather than an exhaustive listings approach and uses user interest data to power personalized recommendations. The app launched in London (Shoreditch/ustwo offices) and prioritizes populating top local shows, with plans to expand city-by-city next year including potential moves to New York and other markets. The team positions monetization as freemium and data-driven (selling additional goods/services and business intelligence), though specific revenue models were not publicly detailed. Dice has secured operational support and product/design resources from ustwo and processes payments via Stripe.

Led · Series A · Oct 2022

Scailyte develops ScaiVision, an AI-powered single-cell omics data analysis platform that analyzes millions of individual cells to identify precise molecular biomarker profiles and link them to clinical outcomes. The ETH spinoff, founded in 2017 and based in Basel, focuses on accelerating drug development and improving clinical trial and personalized cancer‑therapy success rates through multimodal biomarker discovery. ScaiVision has been tested in clinical settings including CAR‑T cell therapies and projects in endometriosis and solid tumors. Strategic partners such as Nilogen, Volv Global and Sirona DX collaborate with Scailyte to advance personalized therapies against cancers and rare diseases. The company recently raised new funding to expand U.S. partnerships in immuno‑oncology and further develop its biomarker technology. Leadership reports growing commercial traction and validation of market need from small patient‑population studies. Scailyte combines single-cell technologies, high-quality datasets and machine learning methods to identify disease-specific biomarkers with a focus on oncology and immunology. Its data analysis platform, ScaiVision, associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints such as diagnosis, progression, severity and treatment response to identify ultra-sensitive biomarker signatures. The company is led by Founder & CEO Dr. Peter Nestorov and is a spin-off of ETH Zurich based in Basel, Switzerland. In a Series A round the company raised CHF6M. The funding round was led by a Swiss family office, Mirabaud bank and existing backers. Scailyte said it will use the proceeds to accelerate growth, expand operations and broaden its business reach. Scailyte is a digital health company that discovers ultrasensitive biomarkers and develops in-vitro diagnostics (IVD) using single-cell technologies and its proprietary data analysis platform, ScaiVision. ScaiVision processes and interprets single-cell proteomics data (mass and flow cytometry) and includes core functionality for analysing single-cell transcriptomics data. The company is advancing assays in the rapidly emerging single-cell data technology field and aims to enable clinical applications of single-cell data. Scailyte plans to build upon its biomarker and IVD pipeline and to develop first clinical applications using single-cell biomarkers. Its pipeline includes biomarker candidates for endometriosis and CTCL, each with a market potential of several hundred million Francs, according to the company. Scailyte completed a pre-series A financing round, raising CHF3.7 million to accelerate development of assays, its biomarker and IVD pipeline, and clinical applications. Scailyte builds artificial intelligence–based software, marketed as ScaiVision, to analyze complex single-cell data for biomedical research, pharmaceutical discovery and precision diagnostics. The company also offers biomarker discovery services to complement customers' analyses with a single-cell perspective. ScaiVision was scheduled for commercial launch at the beginning of 2019 and the company intends to use new funding to accelerate its development and market entry. Scailyte has begun its first clinical study and is negotiating biomarker-discovery engagements with leading blue-chip companies. Founded in June 2017 and led by CEO Peter Nestorov, the company is based in Luzern, Switzerland. The recent seed financing provides resources to make ScaiVision more accessible and attractive to a wider range of customers.

Participated · Series D · Sep 2022

Varjo develops military-grade virtual and mixed reality hardware and software used to replicate real-world scenarios for training across land, sea, and air. Its product lineup includes the XR-4 Series and the government-compliant XR-4 Secure Edition, and its solutions are compatible with professional 3D software, image generators, and advanced simulator hardware. The company says its technology is adopted by more than 25% of Fortune 100 companies to enhance operational processes. Varjo emphasizes immersion, performance, and security for industrial and defence customers and aims to modernize training methods to improve speed, effectiveness, and cost-efficiency. The recent investment from THEON is intended to strengthen Varjo’s capabilities to deliver military-grade realism through next-generation immersive technologies. A strategic partnership with THEON will support multiple product and commercial initiatives aligned with expanding mission-critical training and simulation impact. Varjo produces premium XR headsets (XR-3, VR-3 and Aero) and integrated software, including the Varjo Reality Cloud streaming platform, aimed at industrial and enterprise applications. The company sells hardware priced roughly $6,500 to $1,500 and offers software subscriptions that appear to start around $1,500 annually. Its customers include Volvo, Lockheed Martin, Boeing, Aston Martin, Kia and about 25% of the Fortune 100, plus various U.S. and European government departments, with focus verticals in design and manufacturing, engineering, education and healthcare. Varjo also develops next-generation offerings (Teleport is in alpha) and holds 69 XR-related patents. Headquartered in Helsinki and founded in 2016 by veterans from Nokia, the company emphasizes independence and capital-efficient operations. Varjo plans to use recent funding to continue headset R&D and to expand software applications and tools for its Reality Cloud. Varjo develops high-end virtual and mixed reality headsets that offer photorealistic, "human-eye" resolution along with integrated eye tracking and broad software compatibility. Its devices are used by enterprise customers including Volvo Cars, Boeing, Audi and Siemens for applications such as astronaut and pilot training, automotive design and product development. The company sells multiple headsets and has a reseller network spanning over 40 countries across North America, Europe, the Middle East and Asia Pacific. Varjo recently expanded sales and direct shipping to key markets including Singapore, Israel, South Korea, Australia and New Zealand. Leadership changes include Timo Toikkanen being named CEO while co-founder Niko Eiden becomes CXO and remains a board member. Varjo also announced a commercial partnership with MeetinVR and plans to use new capital to accelerate global expansion and further develop hardware and software products. Varjo develops high-resolution VR and XR headsets that the company says achieve 'human-eye resolution,' claiming an effective resolution of 50 megapixels per eye and a roughly 20× bump over existing consumer headsets. The product is targeted at design-driven and industrial industries including simulation and training, architecture, automotive, aerospace, manufacturing, engineering, construction, and industrial design. Varjo says it is on track to commercially launch its VR headset later this year and plans an AR/XR add-on in the first half of 2019. The company has provided prototypes to and is iterating with partners such as Airbus, Audi, BMW, Volkswagen, and Lilium. Financially, Varjo has raised a total of $46 million to date, including the recent $31 million Series B. The company was founded in 2016 and is based in Helsinki. Varjo develops mixed-reality headsets and demonstrated its devices at Slush in Helsinki. The company announced it will start shipping Alpha prototypes by the end of 2017 and Beta prototypes in Q1 2018. A commercial launch is planned for sometime in 2018. Financially, Varjo announced a new $6.7M investment from Tekes, which follows an $8.2M Series A round in September. Varjo also disclosed partnerships with 20th Century Fox, Airbus, Audi, Technicolor, BMW and Volkswagen to provide feedback and aid product development. CEO Urho Konttori said the company is perfecting the technology and plans to launch a "profoundly revolutionary VR/XR headset" by the end of 2018.